No clear answer
FcRn / IgG reduction, IVIG, plasma exchange: prevent or delay MS in early MS (CIS or RIS)
early MS (CIS or RIS) · FcRn / IgG reduction, IVIG, plasma exchange
Trials have tried this, but none was a controlled phase 2 or 3 trial with a readable result.
- Trials
- 1
- Running now
- 0
- Controlled phase 2/3 trials
- 0
- People in controlled trials
- 0
How the verdict was reached
No result yet
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| Procedure other, trial | Not a drug-phase study | 61 | 2016 | Paper found, not read | Not counted: not randomised |
Counted: 0. Will count later: 0. Not counted: 1.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026First listed as No clear answer
Related hypotheses
Assembled by software from public sources.